Results 241 to 250 of about 4,435,982 (345)
ABSTRACT Liver injury can lead to severe acute liver failure and even death in patients. Artesunate (ART), which is a derivative of artemisinin that has been approved by the FDA for the treatment of malaria, has significant regulatory effects on cell death and inflammation.
Zhe Zhang +17 more
wiley +1 more source
Metabolic Syndrome and Outcome Predictions: Friends or Foes? [PDF]
Menotti A, Puddu PE.
europepmc +1 more source
This study reports the development of a fully humanized bispecific T cell engager targeting IL13RA2, a tumor‐associated antigen enriched in glioblastoma. This off‐the‐shelf immunotherapy drives potent, antigen‐dependent T cell activation and tumor killing, and prolongs survival in experimental GBM and other solid tumors models without detectable off ...
Joseph T. Duffy +16 more
wiley +1 more source
Editorial: Novel strategies for the clinical management of cardiovascular-kidney-metabolic syndrome. [PDF]
Shen Y, Han J, Ding X.
europepmc +1 more source
WP(Pip) is a mixture of whey protein and piperine‐loaded nanoemulsion stabilized by WP through microfluidic homogenization. Acting as a “smart key,” piperine opens epithelial tight junctions to enhance absorption of whey protein and, thereby increasing circulating amino acid availability, synergistically up‐regulates the mTOR signaling pathway in ...
Qing Yue +10 more
wiley +1 more source
3D body shape-based phenotyping for precision risk stratification of metabolic syndrome. [PDF]
Ran Z +17 more
europepmc +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Development and validation of a prediction model for cardiovascular-kidney-metabolic syndrome progression: a multicenter study. [PDF]
Tu J +5 more
europepmc +1 more source

